979 results on '"Pfisterer, Matthias"'
Search Results
2. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
3. Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts
4. Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus
5. Prognostic Usefulness of Cardiac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics' Outcome Trial)
6. Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients
7. Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index
8. Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials)
9. Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials
10. Novel concept to guide systolic heart failure medication by repeated biomarker testing—results from TIME-CHF in context of predictive, preventive, and personalized medicine
11. Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study
12. Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes.
13. Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy
14. Differential Prognostic Impact of Resting Heart Rate in Older Compared With Younger Patients With Chronic Heart Failure—Insights From TIME-CHF
15. Proactive Strategic Behavior and its Relationship With Other Proactive Behaviors
16. Prognostic Value of “Routine” Cardiac Stress Imaging 5 Years After Percutaneous Coronary Intervention: The Prospective Long-Term Observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING Study
17. Interaction Between Pulmonary Hypertension and Diastolic Dysfunction in an Elderly Heart Failure Population
18. Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF)
19. Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes — results from the BASKET PROVE trial
20. Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease
21. Impact of stent diameter and length on in‐stent restenosis after DES vs BMS implantation in patients needing large coronary stents—A clinical and health‐economic evaluation
22. Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy
23. Drug Eluting and Bare Metal Stents in People with and without Diabetes: Collaborative Network Meta-Analysis
24. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
25. Raised cardiac troponins: Causes extend beyond acute coronary syndromes
26. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials
27. Management of stable coronary artery disease
28. Predictors of early readmission or death in elderly patients with heart failure
29. Who am I (not)? Identity in the changing world of work
30. Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents
31. Impact of worsening renal function related to medication in heart failure
32. Comparison of Six-Month Outcomes for Primary Percutaneous Revascularization for Acute Myocardial Infarction With Drug-Eluting Versus Bare Metal Stents (from the APEX-AMI Study)
33. Percutaneous coronary intervention in the Occluded Artery Trial: Procedural success, hazard, and outcomes over 5 years
34. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina—Comparison of the effects of drug-eluting versus bare-metal stents
35. Sudden Cardiac Death in Patients With Silent Myocardial Ischemia After Myocardial Infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II])
36. How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure?
37. Supplement to: Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
38. Use of B-type natriuretic peptide outside of the emergency department
39. Outpatient Rehabilitation in Patients With Coronary Artery and Peripheral Arterial Occlusive Disease
40. Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: Results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial
41. Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification
42. Drug-eluting versus bare-metal stents in large coronary arteries
43. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
44. Interrelation of ST-segment depression during bicycle ergometry and extent of myocardial ischaemia by myocardial perfusion SPECT
45. Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?
46. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial
47. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
48. Long-term safety of drug-eluting stents
49. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
50. Drug Treatment of Chronic Heart Failure in the Elderly
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.